The study examined 20 spontaneous canine gliomas, histologically classified according to human CNS tumor criteria. Through an extensive immunohistochemical analysis using markers such as Nestin and CD133 to detect neural precursors, GFAP, S-100, and Olig2 for glial lineage identification, and proliferation marker Ki67, the research provides compelling evidence supporting the cancer stem cell (CSC) hypothesis in dogs.
Higher-grade tumors—such as anaplastic oligodendrogliomas and glioblastomas—showed markedly elevated expression of Nestin and CD133, confirming a greater population of undifferentiated neural precursors. While differentiated neuronal markers remained largely absent, some high-grade tumors expressed doublecortin (DCX), suggesting limited neurogenic activity within malignancies.
Neurosphere assays from tumor center and periphery demonstrated that every sample contained proliferative, self-renewing precursor cells. These cells showed multipotential differentiation into neural lineages, further reinforcing that CSCs contribute to sustaining and advancing canine gliomas.
Parallel investigation of the subventricular zone (SVZ) of adult dogs confirmed a structurally conserved neurogenic niche similar to that of humans and other mammals. The presence of migratory neuroblasts outside the SVZ highlights the dynamic neurogenic potential in adult canine brains, offering valuable translational insight.
Together, these findings establish dogs as a powerful comparative model for studying glioma biology, neurogenesis, and potential CSC-targeted therapies. The work underscores the importance of neural precursor populations in tumor progression and provides groundwork for identifying novel therapeutic targets.
Source: Flores, F. (2016). The cancer stem cell hypothesis in spontaneous canine gliomas: from tumors to neurogenesis in the adult dog. Biology & Medicine. Includes immunohistochemical and neurogenic niche analyses supporting CSC dynamics in canine gliomas.
